Invitae Corp (NYSE:NVTA)
| 39.83 Delayed Data As of 4:41pm ET |  +0.76 / +1.95%Today’s Change | 7.42 Today|||52-Week Range 40.95 | +146.93% Year-to-Date |
Latest NVTA News | Press Releases
| Invitae: Revolutionizing Genetic Testing Sep 08 / Seeking Alpha - Paid Partner Content | 3 Important Things I've Learned Reviewing ARK's ETFs Aug 24 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 39.07 |
| Today’s open | 39.87 |
| Day’s range | 38.46 - 40.95 |
| Volume | 6,401,194 |
| Average volume (3 months) | 2,935,845 |
| Market cap | $4.3B |
Data as of 4:41pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | -37.41% |
| Earnings growth (this year) | -26.43% |
| Earnings growth (next 5 years) | +4.00% |
| Revenue growth (last year) | +46.80% |
| P/E ratio | NM |
| Price/Sales | 6.76 |
| Price/Book | 8.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NTRANatera Inc | -0.31 | -0.51% |
| NEONeogenomics Inc | +0.98 | +2.81% |
| ---- | ||
| --iKang Healthcare Gro... | 0.00 | 0.00% |
Data as of 3:59pm ET, 09/18/2020
Financials
| Next reporting date | November 9, 2020 |
| EPS forecast (this quarter) | -$0.65 |
| Annual revenue (last year) | $216.8M |
| Annual profit (last year) | -$242.0M |
| Net profit margin | -111.60% |
Profile
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters San Francisco, California |
Forecasts
